STOCK TITAN

Viatris (VTRS) director takes 2,756 deferred stock units instead of cash fees

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Groothuis Leo Frans reported acquisition or exercise transactions in this Form 4 filing.

Viatris Inc. director Leo Frans Groothuis received a grant of 2,756 deferred stock units (DSUs) on June 30, 2026 as compensation in lieu of cash quarterly non-employee director fees. Each DSU is fully vested and represents one share of Viatris common stock, deliverable upon certain future events such as termination of service or a change in control.

Positive

  • None.

Negative

  • None.
Insider Groothuis Leo Frans
Role null
Type Security Shares Price Value
Grant/Award Deferred Stock Units 2,756 $15.88 $44K
Holdings After Transaction: Deferred Stock Units — 2,756 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Deferred stock units granted 2,756 units Automatic grant on June 30, 2026
Reference share price $15.88 per share June 30, 2026 closing price of Viatris common stock
Underlying common shares 2,756 shares Each DSU represents one share of common stock
Shares following transaction (DSUs) 2,756 units Total deferred stock units held after grant
Deferred Stock Units financial
"the reporting person was automatically granted 2,756 deferred stock units (DSUs)"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
non-employee director fees financial
"election to receive payment of quarterly non-employee director fees in the form of DSUs"
change in control financial
"upon the earliest of the reporting person's termination of service ... or a change in control"
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Groothuis Leo Frans

(Last)(First)(Middle)
1000 MYLAN BOULEVARD

(Street)
CANONSBURG PENNSYLVANIA 15317

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Viatris Inc [ VTRS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)06/30/2026A2,756 (1) (1)Common Stock2,756$15.882,756D
Explanation of Responses:
1. On June 30, 2026, the reporting person was automatically granted 2,756 deferred stock units (DSUs) pursuant to the reporting person's election to receive payment of quarterly non-employee director fees in the form of DSUs. This grant was made in lieu of cash fees, based on the June 30, 2026 closing price of $15.88 per share of common stock of Viatris Inc. (Viatris). Each DSU is fully vested and represents the right to receive one share of common stock of Viatris. The DSUs settle in shares of common stock upon the earliest of the reporting person's termination of service as a non-employee director, the reporting person's death or disability, or a change in control.
/s/ Kevin Macikowski, by power of attorney07/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Viatris (VTRS) director Leo Frans Groothuis report?

Leo Frans Groothuis reported receiving 2,756 deferred stock units from Viatris as director compensation. The units were granted automatically instead of cash quarterly fees and are fully vested, each representing one share of common stock to be delivered in the future.

How many Viatris (VTRS) deferred stock units were granted to the director?

The director received 2,756 deferred stock units from Viatris. These units were issued based on the June 30, 2026 closing price and are structured to convert into 2,756 shares of common stock upon specified future triggering events.

At what share price were the Viatris (VTRS) deferred stock units valued?

The deferred stock units were valued using a Viatris closing share price of $15.88 on June 30, 2026. This price determined how many DSUs the director received instead of cash quarterly non-employee director fees for that period.

When will the Viatris (VTRS) deferred stock units for the director settle into shares?

The deferred stock units will settle into Viatris common shares upon the earliest of the director’s termination of service, death, disability, or a change in control. Until then, they remain as fully vested DSUs representing future stock delivery rights.

Are the Viatris (VTRS) deferred stock units granted to the director immediately vested?

Yes, each deferred stock unit granted to the director is fully vested at grant. Although vested, the DSUs only convert into shares of Viatris common stock upon certain future events, such as termination of service, death, disability, or a change in control.

Was this Viatris (VTRS) director grant a market purchase or a compensation award?

This was a compensation award, not a market purchase. The director elected to receive quarterly non-employee director fees in deferred stock units, which were automatically granted based on Viatris’s June 30, 2026 closing share price instead of receiving cash.